Abstract Number: 822 • 2019 ACR/ARP Annual Meeting
Cigarette Smoking Is a Risk Factor for ANCA-Associated Vasculitis
Background/Purpose: ANCA-associated vasculitis (AAV) is a systemic small vessel vasculitis of unclear etiology associated with excess morbidity and mortality compared to the general population. Environmental…Abstract Number: 2740 • 2018 ACR/ARHP Annual Meeting
Clinical and Laboratory Characteristics of ANCA-Associated Vasculitis in Pediatric and Young Adult Patients: A Retrospective Review
Background/Purpose: ANCA-associated vasculitis (AAV) is a heterogenous group of small-vessel vasculitides that typically affects the kidneys, respiratory tract, and other organ systems. The onset of…Abstract Number: 1749 • 2017 ACR/ARHP Annual Meeting
The Epidemiology of ANCA Associated Vasculitis in the U.S.: A 20 Year Population Based Study
Background/Purpose: ANCA-associated vasculitis (AAV) is rare, with a worldwide reported annual incidence ranging from 1.2 to 2.0 cases per 100,000 individuals and a prevalence of…Abstract Number: 1927 • 2016 ACR/ARHP Annual Meeting
Relapses in Patients with ANCA-Associated Vasculitis: A Retrospective Study on Severity and Organ Involvement Compared to Initial Onset
Background/Purpose: Despite progress in induction and maintenance therapy in ANCA-associated vasculitis (AAV), relapses remain the main challenge in this disease with a rate above 50%.…Abstract Number: 1928 • 2016 ACR/ARHP Annual Meeting
Treatment of ANCA Associated Vasculitis in the Very Elderly
Background/Purpose: Anti-neutrophil cytoplasmic antibody associated vasculitis (AAV) are a group of disorders predominantly affecting older patients and frequently presenting with acute kidney injury. Despite the…Abstract Number: 1935 • 2016 ACR/ARHP Annual Meeting
Hypertrophic Pachymeningitis in a Population with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Study in a Single Japanese Institution
Background/Purpose: Hypertrophic pachymeningitis (HP) is an inflammatory disorder causing focal and diffuse thickening of the dura mater. It is realized that anti-neutrophil cytoplasmic antibody (ANCA)-associated…Abstract Number: 854 • 2015 ACR/ARHP Annual Meeting
Nationwide Incidence of Anti Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis in Iceland
Background/Purpose: The Icelandic population is geographically isolated, genetically homogenous and with distinct environmental exposures. Deviations in disease occurrence compared to other Western countries might provide…Abstract Number: 855 • 2015 ACR/ARHP Annual Meeting
Seasonality in ANCA-Associated Vasculitis
Background/Purpose: pathogenesis of ANCA-associated vasculitis (AAV) is multifactorial and most likely involves the interaction of environmental and genetic factors. Environmental seasonal exposures may play a role in the manifestation…Abstract Number: 863 • 2015 ACR/ARHP Annual Meeting
Contribution of MPO-/PR3-ANCA Tests to the Diagnosis of ANCA-Associated Vasculitis in a Community Hospital: Evaluation of 2,782 Samples
Background/Purpose: The purpose of this study was to evaluate the contribution of MPO-/PR3-ANCA tests to the diagnosis of ANCA-associated vasculitis (AAV). Methods: We extracted patients…Abstract Number: 866 • 2015 ACR/ARHP Annual Meeting
High Rate and Bimodal Pattern of Severe Infection in a Selected ANCA Associated Vasculitis Cohort
Background/Purpose : Increased rate of severe infection (SI) in patients who exposed to immunosuppressive drugs has been a well-known complication in inflammatory rheumatic diseases. However,…Abstract Number: 868 • 2015 ACR/ARHP Annual Meeting
Risk Factors for Cytomegalovirus Reactivation in Patients with Antineutrophil Cytoplasmic Antibody -Associated Vasculitis
Background/Purpose: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a disease entity characterized by inflammatory cell infiltration and necrosis of blood vessel walls. AAV usually needs…Abstract Number: 879 • 2015 ACR/ARHP Annual Meeting
Diffuse Alveolar Hemorrhage Secondary to ANCA-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes
Background/Purpose: The interpretation of the literature on diffuse alveolar hemorrhage (DAH) secondary to ANCA-associated vasculitis (AAV) has been complicated by the small size of…Abstract Number: 1757 • 2014 ACR/ARHP Annual Meeting
An Analysis of the Incidence and Characteristics of ANCA Positive Vasculitis before and after the Christchurch Earthquake
Background/Purpose At 1251 on 22 February 2011 a magnitude 6.4 earthquake struck Christchurch killing up to 185 people and causing widespread damage to buildings in…Abstract Number: 284 • 2012 ACR/ARHP Annual Meeting
Treatment and Outcome of ANCA-Associated Vasculitis in Children: A Pilot Study
Background/Purpose: Childhood ANCA vasculitides are rare, yet organ- or even life-threatening systemic vasculitides. Children most frequently present with rapidly evolving, severe disease such as pulmonary-renal…Abstract Number: 285 • 2012 ACR/ARHP Annual Meeting
Rituximab for Severe Disease Flares in Childhood ANCA Vasculitides
Background/Purpose: Children with ANCA vasculitides frequently present with life-threatening organ manifestations including alveolar hemorrhage, critical subglottic stenosis and renal failure due to rapidly progressive glomerulonephritis…
ACR Meeting Abstracts